Hope for chronic kidney disease as KBP Biosciences’ KBP-5074 shows promise
In early December, KBP Biosciences shared results for their BLOCK-CKD Phase IIb study, which has shown KBP-5074 could improve treatment…
In early December, KBP Biosciences shared results for their BLOCK-CKD Phase IIb study, which has shown KBP-5074 could improve treatment…
ReCor Medical’s Paradise ultrasound renal denervation (RDN) system has recently received Breakthrough Device Designation from the FDA. If approved, the…